DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 33 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,184 | -40.3% | 4,335 | 0.0% | 0.00% | – |
| Q2 2023 | $18,727 | +182.3% | 4,335 | 0.0% | 0.00% | – |
| Q1 2023 | $6,633 | -3.2% | 4,335 | 0.0% | 0.00% | – |
| Q4 2022 | $6,850 | +37.0% | 4,335 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | -44.4% | 4,335 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -18.2% | 4,335 | 0.0% | 0.00% | – |
| Q1 2022 | $11,000 | -31.2% | 4,335 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | -5.9% | 4,335 | 0.0% | 0.00% | – |
| Q3 2021 | $17,000 | -10.5% | 4,335 | 0.0% | 0.00% | – |
| Q2 2021 | $19,000 | -52.5% | 4,335 | 0.0% | 0.00% | – |
| Q1 2021 | $40,000 | -9.1% | 4,335 | 0.0% | 0.00% | – |
| Q4 2020 | $44,000 | +144.4% | 4,335 | 0.0% | 0.00% | – |
| Q3 2020 | $18,000 | – | 4,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,197,245 | $2,993,000 | 1.24% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 265,000 | $663,000 | 0.40% |
| COOPERMAN LEON G | 812,508 | $2,031,270 | 0.11% |
| Ikarian Capital, LLC | 221,252 | $553,000 | 0.07% |
| Shay Capital LLC | 10,000 | $25,000 | 0.00% |
| Sandy Cove Advisors, LLC | 1,200 | $3,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,269 | $3,000 | 0.00% |
| Patriot Financial Group Insurance Agency, LLC | 1,300 | $3,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 20,603 | $52,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |